Influence of Obesity on Propofol Pharmacokinetics During Cardiopulmonary Bypass

NCT02477982 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2015-06-23

No results posted yet for this study

Summary

The primary objective of this study is to develop a descriptive and predictive pharmacokinetics model propofol disposition during cardiopulmonary bypass (CPB) in obese and lean patients.

Conditions

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2014-01-31
Completion
2014-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02477982 on ClinicalTrials.gov